States must jointly negotiate uniform vaccine price with manufacturers: P Chidambaram

P Chidambaram also accused the central government of having abdicated its responsibility and surrendering to corporate profiteering.

PTI
April 23, 2021 / 01:56 PM IST

P Chidambaram (File image)

Terming the Centre's decision to allow multiple prices for vaccines "discriminatory", senior Congress leader P Chidambaram on Friday suggested states to jointly form a price negotiation committee to work out a uniform rate with the manufacturers.

Chidambaram also accused the central government of having abdicated its responsibility and surrendering to corporate profiteering.

"The central government's decision to allow multiple prices for vaccines is discriminatory and regressive. States must unanimously reject the decision.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

"The best way forward is for the state governments to jointly form a Price Negotiation Committee and offer to negotiate a uniform price with the two vaccine manufacturers," the Congress leader said in a series of tweets.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

He said the joint purchasing power of the state governments would force the manufacturers to agree to a uniform price.

"States must take the initiative. The central government has abdicated its responsibility and surrendered to corporate profiteering," Chidambaram added.

The Centre announced on Monday that everyone above 18 years of age will be eligible for COVID-19 vaccination from May 1, while private hospitals and states will be able to buy the shots from manufacturers.

It also said vaccine manufacturers would be free to supply 50 percent of the doses to the state governments and in the open market for which they will have to make an advance declaration of the price before May 1.

Serum Institute of India announced a price of Rs 400 per dose for its COVID-19 vaccine 'Covishield' for state governments and Rs 600 per dose for private hospitals.

Follow our full coverage of the coronavirus pandemic here.
PTI
TAGS: #coronavirus #COVID-19 vaccine #Current Affairs #India #P Chidambaram
first published: Apr 23, 2021 01:56 pm